UCSF launches $250M initiative to develop living therapeutics

(University of California - San Francisco) UC San Francisco is launching a new initiative to propel the development of living therapeutics -- a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease - and bring them quickly to patients. The Living Therapeutics Initiative (LTI) will bring together UCSF's vast scientific and clinical expertise to accelerate research and quickly advance promising therapies to clinical trials for patients who have few, if any, good treatment options.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news